Literature DB >> 6961859

The role of endorphins in stress-induced analgesia.

D D Kelly.   

Abstract

We have seen that exposure of an organism to any of a wide range of stressful situations can induce alterations in sensitivity to pain that outlast the exposure. Not all stressors induce analgesia; among those that do not are some that produce maximal elevations in plasma beta-endorphin, ACTH, and adrenal corticosteroids. Some examples of SIA are sensitive to opiate receptor blockade by naloxone, but others are not. Hypophysectomy produces a similarly uneven profile of effects across different stressors. This diversity has often been interpreted as evidence for the existence of an array of pain inhibitory systems, with differing physiological properties and activated by different stressors. However, it might also suggest that stressors can prompt a variety of behavioral changes, many of which can be interpreted as analgesia if a pain reflex test is employed as the dependent measure.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6961859     DOI: 10.1111/j.1749-6632.1982.tb39499.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  4 in total

1.  Up-regulation of mu-opioid receptors in the spinal cord of morphine-tolerant rats.

Authors:  Subrata Basu Ray; Himanshu Gupta; Yogendra Kumar Gupta
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

2.  Vasopressin and stress-induced antinociception in the mouse.

Authors:  S L Hart; A O Oluyomi
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  Post-natal morphine differentially affects opiate and stress analgesia in adult rats.

Authors:  D Arjune; R J Bodnar
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

4.  Mice with cisplatin and oxaliplatin-induced painful neuropathy develop distinct early responses to thermal stimuli.

Authors:  Lauren E Ta; Philip A Low; Anthony J Windebank
Journal:  Mol Pain       Date:  2009-02-26       Impact factor: 3.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.